Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
2024 Standout
Works of Chitra Mani being referenced
A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
2015
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chitra Mani | 211 | 260 | 233 | 17 | 547 | |
| Adrian Davies | 200 | 195 | 280 | 17 | 624 | |
| Kim J. Rich | 173 | 280 | 126 | 21 | 596 | |
| David J. Porubek | 178 | 199 | 140 | 18 | 506 | |
| Alan C. Gough | 331 | 311 | 114 | 12 | 638 | |
| Hong Zuo | 173 | 202 | 281 | 17 | 570 | |
| Pia Wegman | 199 | 306 | 324 | 14 | 617 | |
| Tomokazu Ohnuma | 309 | 210 | 92 | 23 | 550 | |
| Stanley Venitt | 234 | 98 | 231 | 18 | 626 | |
| C. Crofton-Sleigh | 201 | 110 | 235 | 17 | 601 | |
| Su Sien Ong | 185 | 200 | 93 | 15 | 548 |
All Works
Loading papers...